U.S., Aug. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07786090) titled 'Mechanistic 129 Xe MRI Study to Assess Therapeutic Response in Fibrotic Interstitial Lung Disease' on Aug. 20.
Brief Summary: The goal of this observational study is to better understand how treatment affects the lungs of adults (ages 18-80) with fibrotic interstitial lung diseases. The main questions it aims to answer are:
* Can advanced imaging detect the effect of currently approved therapies on people with fibrotic interstitial lung diseases?
* What is the relationship between the response to therapy and the imaging response to therapy?
Study Start Date: Nov., 2026
Study Type: OBSERVATIONAL
Condition:
Fibrotic Interstitial...